Type III hypersensitivity

50,800views

Type III hypersensitivity

NMBE hematoinmuno

NMBE hematoinmuno

Blood histology
Blood components
Erythropoietin
Blood groups and transfusions
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Iron deficiency anemia
Beta-thalassemia
Alpha-thalassemia
Sideroblastic anemia
Anemia of chronic disease
Lead poisoning
Hemolytic disease of the newborn
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Pyruvate kinase deficiency
Paroxysmal nocturnal hemoglobinuria
Sickle cell disease (NORD)
Hereditary spherocytosis
Aplastic anemia
Fanconi anemia
Megaloblastic anemia
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Diamond-Blackfan anemia
Acute intermittent porphyria
Porphyria cutanea tarda
Hemophilia
Vitamin K deficiency
Bernard-Soulier syndrome
Glanzmann's thrombasthenia
Hemolytic-uremic syndrome
Immune thrombocytopenia
Thrombotic thrombocytopenic purpura
Von Willebrand disease
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Antithrombin III deficiency
Factor V Leiden
Protein C deficiency
Protein S deficiency
Antiphospholipid syndrome
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelodysplastic syndromes
Polycythemia vera (NORD)
Myelofibrosis (NORD)
Essential thrombocythemia (NORD)
Langerhans cell histiocytosis
Multiple myeloma
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Thymus histology
Spleen histology
Lymph node histology
Cytokines
Innate immune system
Complement system
T-cell development
B-cell development
MHC class I and MHC class II molecules
T-cell activation
B-cell activation, differentiation, and contraction
Antibody classes
Type I hypersensitivity
Type II hypersensitivity
Type III hypersensitivity
Type IV hypersensitivity
Graft-versus-host disease
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Common variable immunodeficiency
IgG subclass deficiency
Hyperimmunoglobulin E syndrome
Thymic aplasia
DiGeorge syndrome
Severe combined immunodeficiency
Adenosine deaminase deficiency
Ataxia-telangiectasia
Hyper IgM syndrome
Wiskott-Aldrich syndrome
Leukocyte adhesion deficiency
Chediak-Higashi syndrome
Chronic granulomatous disease
Complement deficiency
Hereditary angioedema
Asplenia
Mycobacterium tuberculosis (Tuberculosis)
Anemia: Clinical
ELISA (Enzyme-linked immunosorbent assay)
HIV and AIDS: Pathology review
HIV (AIDS)
Atopic dermatitis
Papulosquamous and inflammatory skin disorders: Pathology review
Bullous pemphigoid
Pemphigus vulgaris
Stevens-Johnson syndrome
Erythema multiforme
Antiplatelet medications
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review

Transcript

Watch video only

Content Reviewers

Having a hypersensitivity means that someone’s immune system has reacted to something in a way that ends up damaging them, as opposed to protecting them.

There are four different hypersensitivities and the third type or type III hypersensitivity reaction happens when antigen-antibody complexes deposit in blood vessel walls, causing inflammation and tissue damage.

Alright so first off, type III hypersensitivity reactions are mediated by immune complexes. Immune complexes, aka antigen-antibody complexes are made of two parts—the antigen and the antibody.

Antibodies, sometimes called immunoglobulins, are produced by plasma cells, which are basically fully matured and differentiated B cells.

Initially these cells make IgM - which can be secreted or bound to the plasma cell surface where it acts as a B cell receptor.

When a B cell undergoes cross-linking of two surface bound IgMs, it then takes up the antigen and presents a piece of it to T helper cells via t cell receptor to the MHC- class II molecule presenting the piece of antigen, along with costimulatory molecule CD4.

The B cell’s CD40 also binds to the T cell’s CD40 ligand, and then the t cell releases cytokines, which results in b cell activation and class switching, or isotype switching, where it changes the type of antibodies it makes.

In type III hypersensitivity reactions, typically B cells will switch from making IgM to making IgG antibodies.

Now remember that all antibodies are specific, right? Meaning that they recognize specific molecules called antigens, the second part of immune complexes.

Antigens can come in all sorts of flavors, some float around in the blood by themselves, and are soluble, but some are bound to cell surfaces.

Immune complexes are formed when antibodies bind to soluble antigens.

Antibodies can also target antigens on cell surfaces, but these are not considered immune complexes.

This is the first major distinction between type II hypersensitivity reactions, which involve antibodies binding to antigens on cell surfaces, and type III hypersensitivity reactions, which involve immune complexes with soluble antigens.

A good example of a type III Hypersensitivity is the autoimmune disease systemic lupus erythematosus, also just called lupus.

In lupus, the IgG antibodies are typically specific for DNA and nucleoproteins, both of which are part of your own cells, making them self-reactive.

Normally, your body should only react to things that are foreign or not-self.

And this is maintained by a process known as tolerance where only non-self-reactive B and T cells are allowed to mature, whereas self-reactive B and T cells aren’t.

This process, though, isn’t perfect and sometimes, some self-reactive cells escape, and these can mount an immune response against autoantigens or self-antigens.

With lupus, a DNA autoantigen may get released from a damaged cell where a circulating self-B cell might find it and bind to it.

If a T helper cell that is also specific for the same DNA autoantigen is close by, it will help activate the B cell and enable it to differentiate into an IgG secreting machine specific to that DNA autoantigen. Now what?

Well, first off, there may be lots of this DNA autoantigen around since DNA is in most human cells, right? Which allows a lot of IgG-DNA autoantigen complexes to form.

Key Takeaways

Type III hypersensitivity is a type of immune response in which antigen-antibody complexes accumulate in the tissues and cause inflammation and tissue damage. This type of hypersensitivity is also known as immune-complex-mediated hypersensitivity. Examples of Type III hypersensitivity reactions include systemic lupus erythematosus, rheumatoid arthritis, and serum sickness. Symptoms can vary depending on the tissues affected and may include joint pain and swelling, rashes, fever, and kidney damage. Treatment options may include removing the triggers, and medications like antihistamines, nonsteroidal anti-inflammatory drugs, and corticosteroids.